Collaboration - February 27, 2019
Orion’s rolling submission to FDA completed
Orion Corporation and Bayer have announced the completion of the rolling submission of a New Drug Application (NDA) for darolutamide to the U.S. Food and Drug Administration (FDA). The submission, which was initiated in December 2018, is based on data from the Phase III ARAMIS trial in men with non-metastatic castration-resistant prostate cancer (nmCRPC) showing […]
Clinical Trials - February 26, 2019
Phase III results from AstraZeneca
AstraZeneca and MSD have announced positive results from the Phase III POLO trial. Results from the trial showed a statistically-significant and clinically-meaningful improvement in progression-free survival (PFS) with Lynparza (olaparib) vs. placebo. The safety and tolerability profile of Lynparza was consistent with previous trials. POLO is a randomized, double-blinded, placebo-controlled trial exploring the efficacy of Lynparza tablets as 1st-line […]
Collaboration - February 12, 2019
Our Nobel Prize issue is out!
Three of the 2018 Nobel Prizes have connections to life sciences, giving us the opportunity to learn more about immune checkpoint therapy, optical tweezers, chirped pulse amplification, directed evolution of enzymes and phage display. We have also had the privilege to speak to eight Laureates, taking part in the lives and careers of eight different […]
Collaboration - January 15, 2019
Swedish & Norwegian researchers have found a measuring tool for optimal antibody effectiveness
Using DNA origami – DNA-based design of precise nanostructures – scientists at Karolinska Institutet in Sweden and at University of Oslo, Norway, have been able to demonstrate the most accurate distance between densely packed antigens in order to get the strongest bond to antibodies in the immune system. The study, which is published in the […]
Collaboration - December 21, 2018
Season’s Greetings from Nordic Life Science
We would like to thank our readers, subscribers and collaboration partners for a fruitful, eventful and fun 2018, and we wish you all a most wonderful holiday season! Nordic Life Science will be back on January 2nd to provide you with the latest news from our exciting life science industry! Until then, here are some […]
Collaboration - December 19, 2018
A new German-Scandinavian life science network project
A new EU project in the program area Öresund-Kattegatt-Skagerak (ÖKS) has been approved. Hanseatic League of Science (HALOS) will build a collaboration between Hamburg and South-West Scandinavia, bring together the four research facilities MAX IV, ESS, DESY and European XFEL, and create a centre for integrated, world-leading Life Science innovation and research. 3.6 million EUR […]
